This Article Full Text Full Text (PDF) All Versions of this Article: 115/8/990    most recent CIRCULATIONAHA.106.648469v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Venn, A. Articles by Britton, J. Search for Related Content PubMed PubMed Citation Articles by Venn, A. Articles by Britton, J. Related Collections Fibrinogen/fibrin Chronic ischemic heart disease Epidemiology Related Article

(Circulation. 2007;115:990-995.)
© 2007 American Heart Association, Inc.

Epidemiology

Exposure to Secondhand Smoke and Biomarkers of Cardiovascular Disease Risk in Never-Smoking Adults

Andrea Venn, PhD; John Britton, MD

From the University of Nottingham, Nottingham, UK.

Correspondence to Dr Andrea Venn, Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Bldg, City Hospital, Nottingham, NG5 1PB, UK. E-mail andrea.venn{at}nottingham.ac.uk

Received June 28, 2006; accepted December 22, 2006.

Background— Exposure to secondhand smoke has been associated with a disproportionately high risk of coronary heart disease, thought to be mediated through inflammation, platelet aggregation, and/or endothelial dysfunction. The epidemiological association between objectively measured exposure to secondhand smoke and biomarkers of heart disease risk has not been investigated, however.

Methods and Results— We have investigated the cross-sectional relation between secondhand smoke exposure, measured objectively as cotinine, and recognized biomarkers of heart disease risk, namely C-reactive protein, homocysteine, fibrinogen, and white blood cell count, in 7599 never-smoking adults from the Third National Health and Nutrition Examination Survey. Compared with subjects with no detectable cotinine, those with detectable but low-level cotinine (range, 0.05 to 0.215 ng/mL) had significantly higher levels of both fibrinogen (adjusted mean difference, 8.9 mg/dL; 95% CI, 0.9 to 17.0; P=0.03) and homocysteine (0.8 µmol/L; 95% CI, 0.4 to 1.1; P<0.001) but not C-reactive protein or white blood cell count. Effect estimates of similar magnitude and significance were seen in subjects in the high category of cotinine exposure (>0.215 ng/mL). The increased levels of fibrinogen and homocysteine seen in relation to secondhand smoke exposure were equivalent to 30% to 45% of those seen for active smoking.

Conclusions— Passive smokers appear to have disproportionately increased levels of 2 biomarkers of cardiovascular disease risk, fibrinogen and homocysteine. This finding provides further evidence to suggest that low-level exposure to secondhand smoke has a clinically important effect on susceptibility to cardiovascular disease.

---

 

CLINICAL PERSPECTIVE

Related Article:

Issue Highlights
Circulation 2007 115: 945. [Extract] [Full Text]

This article has been cited by other articles:

				G. Nagel, F. J. Arnold, M. Wilhelm, B. Link, I. Zoellner, and W. Koenig Environmental tobacco smoke and cardiometabolic risk in young children: results from a survey in south-west Germany Eur. Heart J., August 1, 2009; 30(15): 1885 - 1893. [Abstract] [Full Text] [PDF]

				N. L. Benowitz, J. T. Bernert, R. S. Caraballo, D. B. Holiday, and J. Wang Optimal Serum Cotinine Levels for Distinguishing Cigarette Smokers and Nonsmokers Within Different Racial/Ethnic Groups in the United States Between 1999 and 2004 Am. J. Epidemiol., January 15, 2009; 169(2): 236 - 248. [Abstract] [Full Text] [PDF]